William Blair Issues Pessimistic Outlook for AEHR Earnings

Key Points

• William Blair has reduced its Q2 2026 earnings estimates for Aehr Test Systems from ($0.03) to ($0.12), reflecting a more pessimistic outlook for the semiconductor company.
• The company's recent quarterly earnings showed matched estimates at $0.01 EPS, but revenue fell short at $11 million compared to the consensus estimate of $13.69 million.
• Aehr Test Systems received a downgrade from Craig Hallum to a "hold" rating with a target price of $24.00, amidst a generally negative consensus outlook on the stock.

Aehr Test Systems (NASDAQ:AEHR - Free Report) - Stock analysts at William Blair decreased their Q2 2026 earnings estimates for Aehr Test Systems in a research report issued to clients and investors on Tuesday, October 7th. William Blair analyst J. Dorsheimer now anticipates that the semiconductor company will post earnings per share of ($0.12) for the quarter, down from their previous estimate of ($0.03). The consensus estimate for Aehr Test Systems' current full-year earnings is $0.10 per share. William Blair also issued estimates for Aehr Test Systems' Q3 2026 earnings at ($0.09) EPS, Q4 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.35) EPS and FY2027 earnings at ($0.10) EPS.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last posted its quarterly earnings data on Monday, October 6th. The semiconductor company reported $0.01 earnings per share for the quarter, meeting analysts' consensus estimates of $0.01. The business had revenue of $11.00 million during the quarter, compared to the consensus estimate of $13.69 million. Aehr Test Systems had a negative return on equity of 2.41% and a negative net margin of 11.71%.During the same period in the prior year, the business posted $0.07 earnings per share.

A number of other equities analysts have also commented on the company. Craig Hallum lowered Aehr Test Systems from a "buy" rating to a "hold" rating and set a $24.00 price objective on the stock. in a research note on Tuesday. Weiss Ratings restated a "sell (d)" rating on shares of Aehr Test Systems in a research report on Wednesday. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Aehr Test Systems has a consensus rating of "Reduce" and a consensus target price of $24.00.

Aehr Test Systems Trading Down 2.7%

NASDAQ AEHR opened at $25.15 on Friday. The firm has a market capitalization of $753.75 million, a PE ratio of -114.32 and a beta of 2.47. The business's 50-day moving average price is $25.00 and its two-hundred day moving average price is $15.91. Aehr Test Systems has a 12 month low of $6.27 and a 12 month high of $34.35.

Insiders Place Their Bets

In other news, Director Rhea J. Posedel sold 18,000 shares of the firm's stock in a transaction dated Tuesday, July 22nd. The stock was sold at an average price of $19.83, for a total value of $356,940.00. Following the completion of the sale, the director directly owned 71,163 shares in the company, valued at $1,411,162.29. This trade represents a 20.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Alistair N. Sporck sold 3,000 shares of the business's stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $14.13, for a total value of $42,390.00. Following the completion of the sale, the vice president directly owned 30,808 shares of the company's stock, valued at $435,317.04. The trade was a 8.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 26,000 shares of company stock worth $506,830. 6.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aehr Test Systems

Hedge funds and other institutional investors have recently modified their holdings of the company. Kennedy Capital Management LLC acquired a new position in shares of Aehr Test Systems during the second quarter worth approximately $5,751,000. AWM Investment Company Inc. raised its holdings in Aehr Test Systems by 28.1% during the first quarter. AWM Investment Company Inc. now owns 1,587,936 shares of the semiconductor company's stock worth $11,576,000 after buying an additional 348,737 shares during the last quarter. Jump Financial LLC raised its holdings in Aehr Test Systems by 324.0% during the first quarter. Jump Financial LLC now owns 119,143 shares of the semiconductor company's stock worth $869,000 after buying an additional 91,043 shares during the last quarter. Penbrook Management LLC lifted its stake in shares of Aehr Test Systems by 205.1% in the second quarter. Penbrook Management LLC now owns 126,250 shares of the semiconductor company's stock valued at $1,632,000 after buying an additional 84,875 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Aehr Test Systems by 37.5% during the first quarter. Wellington Management Group LLP now owns 276,573 shares of the semiconductor company's stock valued at $2,016,000 after buying an additional 75,500 shares during the last quarter. Institutional investors own 69.69% of the company's stock.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.